Cisen Pharmaceutical Hits Day Low of CNY 15.11 Amid Price Pressure

Cisen Pharmaceutical has experienced a notable decline today, with the stock dropping by 5.52% as of March 23, 2026. The stock reached an intraday low of CNY 15.11, reflecting a challenging trading environment. Over the past week, Cisen has seen a decrease of 10.41%, and its performance over the past month shows a decline of 11.2%. In terms of annual performance, the stock has gained 11.17%, which is slightly below the China Shanghai Composite's 13.33% return. However, year-to-date, Cisen's performance has been negative, down 12.07%, compared to the composite's decline of 3.92%. Financial metrics indicate that Cisen has faced difficulties, with net sales for the last nine months declining by 12.88%. The company has reported negative results for three consecutive quarters, and its inventory turnover ratio stands at a low 2.15 times. Despite these challenges, Cisen maintains a return on equity of 7.41% and a price-to-book ratio of 1.48, suggesting a valuation that may attract attention in the mid-cap pharmaceuticals and biotechnology sector.